BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12837578)

  • 1. VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis.
    Nagy JA; Dvorak AM; Dvorak HF
    Trends Cardiovasc Med; 2003 Jul; 13(5):169-75. PubMed ID: 12837578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of placental growth factor.
    De Falco S; Gigante B; Persico MG
    Trends Cardiovasc Med; 2002 Aug; 12(6):241-6. PubMed ID: 12242046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The placenta growth factor in skin angiogenesis.
    Odorisio T; Cianfarani F; Failla CM; Zambruno G
    J Dermatol Sci; 2006 Jan; 41(1):11-9. PubMed ID: 16216466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
    Luttun A; Tjwa M; Moons L; Wu Y; Angelillo-Scherrer A; Liao F; Nagy JA; Hooper A; Priller J; De Klerck B; Compernolle V; Daci E; Bohlen P; Dewerchin M; Herbert JM; Fava R; Matthys P; Carmeliet G; Collen D; Dvorak HF; Hicklin DJ; Carmeliet P
    Nat Med; 2002 Aug; 8(8):831-40. PubMed ID: 12091877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
    Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.
    Pipp F; Heil M; Issbrücker K; Ziegelhoeffer T; Martin S; van den Heuvel J; Weich H; Fernandez B; Golomb G; Carmeliet P; Schaper W; Clauss M
    Circ Res; 2003 Mar; 92(4):378-85. PubMed ID: 12600898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
    Eriksson A; Cao R; Pawliuk R; Berg SM; Tsang M; Zhou D; Fleet C; Tritsaris K; Dissing S; Leboulch P; Cao Y
    Cancer Cell; 2002 Feb; 1(1):99-108. PubMed ID: 12086892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta growth factor is not required for exercise-induced angiogenesis.
    Gigante B; Tarsitano M; Cimini V; De Falco S; Persico MG
    Angiogenesis; 2004; 7(3):277-84. PubMed ID: 15609082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis.
    Fujii T; Yonemitsu Y; Onimaru M; Inoue M; Hasegawa M; Kuwano H; Sueishi K
    Atherosclerosis; 2008 Sep; 200(1):51-7. PubMed ID: 18258238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
    Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
    Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.
    Schomber T; Kopfstein L; Djonov V; Albrecht I; Baeriswyl V; Strittmatter K; Christofori G
    Cancer Res; 2007 Nov; 67(22):10840-8. PubMed ID: 18006829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
    Deissler HL; Deissler H; Lang GK; Lang GE
    Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical role of placental growth factor in the induction of inflammation and edema formation.
    Oura H; Bertoncini J; Velasco P; Brown LF; Carmeliet P; Detmar M
    Blood; 2003 Jan; 101(2):560-7. PubMed ID: 12393422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual delivery of placental growth factor and vascular endothelial growth factor from poly(hydroxyethyl methacrylate-co-methyl methacrylate) microcapsules containing doubly transfected luciferase-expressing L929 cells.
    Cheng D; Sefton MV
    Tissue Eng Part A; 2009 Aug; 15(8):1929-39. PubMed ID: 19125649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
    Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
    Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders.
    Autiero M; Luttun A; Tjwa M; Carmeliet P
    J Thromb Haemost; 2003 Jul; 1(7):1356-70. PubMed ID: 12871269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor.
    Pettersson A; Nagy JA; Brown LF; Sundberg C; Morgan E; Jungles S; Carter R; Krieger JE; Manseau EJ; Harvey VS; Eckelhoefer IA; Feng D; Dvorak AM; Mulligan RC; Dvorak HF
    Lab Invest; 2000 Jan; 80(1):99-115. PubMed ID: 10653008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
    Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
    Cai J; Ahmad S; Jiang WG; Huang J; Kontos CD; Boulton M; Ahmed A
    Diabetes; 2003 Dec; 52(12):2959-68. PubMed ID: 14633857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction.
    Takeda Y; Uemura S; Iwama H; Imagawa K; Nishida T; Onoue K; Takemoto Y; Soeda T; Okayama S; Somekawa S; Ishigami K; Takaoka M; Kawata H; Kubo A; Horii M; Nakajima T; Saito Y
    Circ J; 2009 Sep; 73(9):1674-82. PubMed ID: 19602778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.